P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety

Clinical trial NCT06973577 · COMPLETED

Trial details

NCT number: NCT06973577
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

ADHD Anxiety Generalized Anxiety Social Anxiety Disorder

Start date: 2025-03-26
Primary completion: 2026-04-22
Enrollment: 315

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.